WS 1 - Mucositis Research
Chair: Sharon Elad
Co-Chair: Karis Cheng
Co-Chair: Paolo Bossi
The Mucositis Study Group will offer a workshop centered on the presentation of original research, both pre-clinical and clinical, by both beginning and experienced investigators. The workshop will provide information about the latest research advances, an informal venue for detailed discussion, and a means of identifying new opportunities for research and collaboration. The workshop will be led by Sharon Elad, MD, Chair of the Mucositis Study Group, along with Vice-Chairs Paolo Bossi, MD, and Karis Cheng, MD.
WS 2 - Sleep, Drowsiness, and Fatigue in Cancer Patients
Co-Chair: Dave Balachandran
Co-Chair: Oxana Palesh
Insomnia and other sleep problems are among the most prevalent and distressing problems reported by cancer patients, and they are often related to fatigue. They may affect ability to tolerate treatment and subsequent survival. Yet such sleep problems are often underdiagnosed and undertreated in this population. This workshop, co-sponsored by three Study Groups, will focus on sleep disturbances in cancer patients, including diagnosis and management. Diwakar Balachandran, MD, and Oxana Palesh, PhD, will lead the workshop. The following Study Group leaders are also involved: Karen Mustian, MD, Chair, Fatigue; David Hui, MD, Chair, Palliative; Irma Verdonck-de-Leeuw, Chair, Rehabilitation, Survivorship, and Quality of Life.
WS 3 - Supportive Care for Patients Undergoing Immunotherapy
Chair: Bernardo Rapoport
Co-Chair: Jean Klastersky
Bernardo Rapoport, MD, will lead this workshop cosponsored by three Study Groups: Oral Care, Skin Toxicities, and Neutropenia, Infection, and Myelosuppression. The workshop will focus on the new class of therapeutic agents known as immune checkpoint inhibitors, which play an important role in the management of melanoma, NSCLC, and other malignancies. The workshop will address the mechanism of action and uses of immune anti-CTL4 and anti-PD1 antibodies, as well as their associated toxicities, including skin side effects, GI toxicities, oral complications, and immune-related infections, among other adverse effects.
WS 4 - End of Life: Global Challenges, Local Solutions - Andrew Davies
Co-Chair: Andrew Davies
Co-Chair: Greg Crawford
Andrew Davies, MD, FRCP, Vice-Chair of the Palliative Care Study Group, will lead this workshop, in which participants will consider what makes a “good death,” as well as how to plan for and manage end-of-life symptoms. This workshop will highlight the evidence for various end-of-life interventions and strategies for providing end-of-life care in challenging situations, with a focus on Australia. David Hui, MD, Chair of the Study Group and Mellar Davis, MD, FCCP, Vice-Chair, will participate in the workshop, along with other experts from Australia, the UK, and US.
WS 5 - Cancer-Related Cognitive Impairment
Chair: Alexandre Chan
Alex Chan, PharmD, Vice-Chair of the Neurological Complications Study Group, will lead this workshop, the first MASCC pre-conference workshop to focus on neurocognition. Participants will learn about the etiology and clinical presentation of cancer-related cognitive impairments, as well as the assessment and management of such problems. Other specific issues to be discussed include biomarkers, genetics, considerations for elderly patients, cultural concerns, and special populations.
WS 6 - Nutritional Care Throughout the Advanced Cancer Journey
Co-Chair: David Hui
Co-Chair: Liz Isenring
The Whole Meal Deal. This workshop will beoffered jointly by two Study Groups. David Hui, MD, Chair of the Palliative Care Study Group, will lead the workshop, along with Liz Isenring, PhD, Chair of the Nutrition and Cachexia Study Group and Vice-Chair Florian Strasser, MD ABHPM. Nutritional issues, such as anorexia-cachexia, bowel obstruction, and dysphagia, are common in patients with advanced cancer and are associated with significant psychosocial distress, decreased function, compromised quality of life and poorer survival. Moreover, nutritional interventions at the end of life are highly controversial. The goals of this workshop are to review existing guidelines and basic nutritional assessments relevant to advanced cancer patients. Participants will learn about novel treatments for cachexia, as well as hydration and artificial nutrition.